Skip to results
Modify your search
NARROW
1-19 of 19
Authors: Gary Zammit
Sort by
Journal Article
Effect of daridorexant on sleep architecture in patients with chronic insomnia disorder: a pooled post hoc analysis of two randomized phase 3 clinical studies
Tobias Di Marco and others
Sleep, Volume 47, Issue 11, November 2024, zsae098, https://doi.org/10.1093/sleep/zsae098
Published: 22 April 2024
Journal Article
Phase advance of bedtimes in Alzheimer’s disease
Donald L Bliwise and others
Sleep, Volume 46, Issue 11, November 2023, zsad191, https://doi.org/10.1093/sleep/zsad191
Published: 04 August 2023
Journal Article
0353 Effect of Lemborexant on Sleep Architecture in Adult and Elderly Subjects with Mild to Severe Obstructive Sleep Apnea
Gary Zammit and others
Sleep, Volume 46, Issue Supplement_1, May 2023, Pages A156–A157, https://doi.org/10.1093/sleep/zsad077.0353
Published: 29 May 2023
Journal Article
0354 Effect of Lemborexant on Sleep Architecture in Subjects with Comorbid Insomnia and Mild Obstructive Sleep Apnea from a Ph 3 Trial
Clete Kushida and others
Sleep, Volume 46, Issue Supplement_1, May 2023, Page A157, https://doi.org/10.1093/sleep/zsad077.0354
Published: 29 May 2023
Journal Article
0364 The Effect of Lemborexant on Polysomnographic Sleep Parameters in Adults with Mild, Moderate, or Severe Obstructive Sleep Apnea
Margaret Moline and others
Sleep, Volume 46, Issue Supplement_1, May 2023, Pages A161–A162, https://doi.org/10.1093/sleep/zsad077.0364
Published: 29 May 2023
Journal Article
344 Daridorexant Improves Total Sleep Time (TST) in Insomnia Patients Without Altering the Proportion of Sleep Stages
Gary Zammit and others
Sleep, Volume 44, Issue Supplement_2, May 2021, Pages A137–A138, https://doi.org/10.1093/sleep/zsab072.343
Published: 03 May 2021
Journal Article
336 Effect of Lemborexant Versus Placebo and Zolpidem on REM Sleep by Quarter Night Intervals in Older Adults with Insomnia Disorder
Gary Zammit and others
Sleep, Volume 44, Issue Supplement_2, May 2021, Page A134, https://doi.org/10.1093/sleep/zsab072.335
Published: 03 May 2021
Journal Article
Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
Mikko Kärppä and others
Sleep, Volume 43, Issue 9, September 2020, zsaa123, https://doi.org/10.1093/sleep/zsaa123
Published: 26 June 2020
Journal Article
0569 Incidence and Duration of Common Adverse Events in a Solriamfetol (JZP-110) Phase 3 Study for Treatment of Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Get access
Russell Rosenberg and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Pages A226–A227, https://doi.org/10.1093/sleep/zsz067.567
Published: 12 April 2019
Journal Article
0407 ACT-541468, A Dual Orexin Receptor Antagonist, For The Treatment Of Insomnia Disorder: A Randomized, Double-Blind, Placebo-Controlled, 5-Period, 5-Treatment Crossover Dose-Response Phase 2 Study In The Elderly
Get access
Gary Zammit and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Page A165, https://doi.org/10.1093/sleep/zsz067.406
Published: 12 April 2019
Journal Article
0367 Lemborexant Treatment for Insomnia: 6-month Safety
Get access
Mikko Kärppä and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Pages A149–A150, https://doi.org/10.1093/sleep/zsz067.366
Published: 12 April 2019
Journal Article
0368 Efficacy and Tolerability of Lemborexant in Female and Male Subjects with Insomnia
Get access
Margaret Moline and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Page A150, https://doi.org/10.1093/sleep/zsz067.367
Published: 12 April 2019
Journal Article
0369 Effect of Lemborexant on Sleep Architecture in Older Adults with Insomnia Disorder
Get access
Margaret Moline and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Page A150, https://doi.org/10.1093/sleep/zsz067.368
Published: 12 April 2019
Journal Article
0375 A Novel Dual Orexin Receptor Antagonist (ACT-541468) to Treat Insomnia: A Randomized, Double-Blind, Placebo-Controlled, Active-Reference Phase 2 Study
Get access
Yves Dauvilliers and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Pages A152–A153, https://doi.org/10.1093/sleep/zsz067.374
Published: 12 April 2019
Journal Article
Dual Orexin Receptor Antagonist, Almorexant, in Elderly Patients With Primary Insomnia: A Randomized, Controlled Study
Get access
Thomas Roth and others
Sleep, Volume 40, Issue 2, 1 February 2017, zsw034, https://doi.org/10.1093/sleep/zsw034
Published: 26 December 2016
Journal Article
The Effect of Changes in Cardiorespiratory Fitness and Weight on Obstructive Sleep Apnea Severity in Overweight Adults with Type 2 Diabetes
Get access
Christopher E. Kline and others
Sleep, Volume 39, Issue 2, February 2016, Pages 317–325, https://doi.org/10.5665/sleep.5436
Published: 01 February 2016
Journal Article
Long-Term Effect of Weight Loss on Obstructive Sleep Apnea Severity in Obese Patients with Type 2 Diabetes
Get access
Samuel T. Kuna and others
Sleep, Volume 36, Issue 5, 1 May 2013, Pages 641–649, https://doi.org/10.5665/sleep.2618
Published: 01 May 2013
Journal Article
Nonrestorative Sleep as a Distinct Component of Insomnia
Get access
Thomas Roth and others
Sleep, Volume 33, Issue 4, April 2010, Pages 449–458, https://doi.org/10.1093/sleep/33.4.449
Published: 01 April 2010
Journal Article
The Taskforce 2000 Survey on Medical Education in Sleep and Sleep Disorders
Get access
Raymond Rosen and others
Sleep, Volume 21, Issue 3, May 1998, Pages 235–238, https://doi.org/10.1093/sleep/21.3.235
Published: 01 May 1998
Advertisement
Advertisement